These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 11365398

  • 1. The great salvage therapy drug juggle.
    Cadman J.
    GMHC Treat Issues; 1998 Apr; 12(4):1-6. PubMed ID: 11365398
    [Abstract] [Full Text] [Related]

  • 2. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [Abstract] [Full Text] [Related]

  • 3. Salvage therapy: still more intuition than data.
    Gilden D.
    GMHC Treat Issues; 1999 Jan; 13(1):6-12. PubMed ID: 11366112
    [Abstract] [Full Text] [Related]

  • 4. Salvage solitaire (or, HAART takes a holiday).
    Mascolini M.
    J Int Assoc Physicians AIDS Care; 1999 Jul; 5(7):10-23. PubMed ID: 11367132
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K.
    Verh K Acad Geneeskd Belg; 2001 Jul; 63(5):447-73. PubMed ID: 11813503
    [Abstract] [Full Text] [Related]

  • 7. Salvage therapy for Indinavir and Ritonavir users.
    TreatmentUpdate; 1999 Jul 01; 11(5):1-2. PubMed ID: 11366926
    [Abstract] [Full Text] [Related]

  • 8. More trouble for adefovir.
    Gilden D.
    GMHC Treat Issues; 1999 Apr 01; 13(4):3. PubMed ID: 11366975
    [Abstract] [Full Text] [Related]

  • 9. Virological and pharmacological factors associated with virological response to salvage therapy after an 8-week of treatment interruption in a context of very advanced HIV disease (GigHAART ANRS 097).
    Delaugerre C, Peytavin G, Dominguez S, Marcelin AG, Duvivier C, Gourlain K, Amellal B, Legrand M, Raffi F, Costagliola D, Katlama C, Calvez V.
    J Med Virol; 2005 Nov 01; 77(3):345-50. PubMed ID: 16173015
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Quadruple-2 protease inhibitors (PI)-therapy does not accelerate viral decay and suppression in PI-naive HIV-1 infected patients with severe immunosuppression and high viral load as compared with standard triple therapy.
    Portilla J, Boix V, Garcia-Henarejos JA, Llopis C, Martínez-Madrid O, Gimeno A, Sánchez-Paya J, Merino E.
    Int J STD AIDS; 2005 Dec 01; 16(12):807-10. PubMed ID: 16336763
    [Abstract] [Full Text] [Related]

  • 14. [Salvage therapy for HIV infection].
    Salzberger B.
    MMW Fortschr Med; 2005 Apr 25; 147 Spec No 1():32-7. PubMed ID: 16385870
    [Abstract] [Full Text] [Related]

  • 15. Salvage therapy.
    Gulick RM.
    AIDS Clin Care; 1999 Sep 25; 11(9):71-3, 77-8. PubMed ID: 11366502
    [Abstract] [Full Text] [Related]

  • 16. New antiretroviral tactics: transitions or mere trends? An interview with Joep Lange,MD,PhD. Interview by Mark Mascolini.
    Mascolini M.
    J Int Assoc Physicians AIDS Care; 1999 Jul 25; 5(7):25-9. PubMed ID: 11367133
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.